Briefing notes
Public health significance of virus mutation detected in Norway
Pandemic (H1N1) 2009 briefing note 17
20 November 2009
Safety of pandemic vaccines
Pandemic (H1N1) 2009 briefing note 16
19 November 2009
Infection of farmed animals with the pandemic virus
Pandemic (H1N1) 2009 briefing note 15
5 November 2009
Experts advise WHO on pandemic vaccine policies and strategies
Pandemic (H1N1) 2009 briefing note 14
30 October 2009
Clinical features of severe cases of pandemic influenza
Pandemic (H1N1) 2009 briefing note 13
16 October 2009
Antiviral use and the risk of drug resistance
Pandemic (H1N1) 2009 briefing note 12
25 September 2009
Pandemic influenza vaccines: current status
Pandemic (H1N1) 2009 briefing note 11
24 September 2009
Measures in school settings
Pandemic (H1N1) 2009 briefing note 10
11 September 2009
Preparing for the second wave: lessons from current outbreaks
Pandemic (H1N1) 2009 briefing note 9
28 August 2009
Recommended use of antivirals
Pandemic (H1N1) 2009 briefing note 8
20 August 2009
Pandemic influenza vaccine manufacturing process and timeline
Pandemic (H1N1) 2009 briefing note 7
6 August 2009
Safety of pandemic vaccines
Pandemic (H1N1) 2009 briefing note 6
6 August 2009
Pandemic influenza in pregnant women
Pandemic (H1N1) 2009 briefing note 5
31 July 2009
Preliminary information important for understanding the evolving situation
Pandemic (H1N1) 2009 briefing note 4
24 July 2009
Changes in reporting requirements for pandemic (H1N1) 2009 virus infection
Pandemic (H1N1) 2009 briefing note 3 (revised)
16 July 2009
WHO recommendations on pandemic (H1N1) 2009 vaccines
Pandemic (H1N1) 2009 briefing note 2
13 July 2009
Viruses resistant to oseltamivir (Tamiflu) identified
Pandemic (H1N1) 2009 briefing note 1
8 July 2009
|
